SGLT2 inhibitors protect against kidney disease in T2DM
(HealthDay)—A class of diabetes drugs, called sodium-glucose co-transporter-2 (SGLT2) inhibitors, protect against kidney disease in patients with type 2 diabetes, according to a review published online Sept. 5 in The Lancet ...
Oct 11, 2019
0
2